PACTR201310000604277Completed未知
Profile of Isoniazid Acetylation Phenotype and Clinical Implications in Rwandan Healthy Subjects and Tuberculosis Patients
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- R
- Enrollment
- 50
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 16 Year(s) to 75 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •Tuberculosis patient
- •Consult the University hospital
Exclusion Criteria
- •under other treatment
- •less than 15 years
- •treated with ARVs
Investigators
Similar Trials
Recruiting
Not Applicable
Polymorphism of metabolisation and clinical implicationsTuberculosisPACTR201406000609270ational University of Rwanda200
Completed
Phase 3
A double blind randomised placebo controlled trial of NAC in bipolar disorder.Bipolar disorderMental Health - Other mental health disordersACTRN12607000074493Stanley Medical Research Institute150
Completed
Phase 3
A comparison between the effect of Isoniazid together with Misoprostol and Misoprostol on abortion in the first three months of pregnancy.IRCT20190819044561N1Iran University of Medical Sciences80
Recruiting
Phase 2
A clinical trial to study the effect of N-acetyl cysteine (NAC)in patients with pulmonary tuberculosisCTRI/2007/091/000012Christian Medical College - Vellore
Recruiting
Phase 3
Evaluation of N-Acetyl Cysteine mouthwash in preventing the occurrence of chemotherapy-induced oral mucositischemotherapy-induced oral mucositis.Oral mucositis (ulcerative)K12.3IRCT20220712055439N1Mazandaran University of Medical Sciences68